Fenwick & West is representing Veracyte in the transaction, and Meitar is representing C2i Genomics. Veracyte, Inc. (Nasdaq: VCYT) announced it has entered into a definitive agreement...
This content is for Standard 1 Year members only. LoginJoin Now